Assessment of Risk Factors of Hepatotoxicity among Tuberculosis Patients
Tuberculosis is a devastating disease caused by Mycobacterium tuberculosis. If left untreated or not properly treated, it could lead to progressive tissue damage and even death. Short-term chemotherapy containing isoniazid, rifampicin. and pyrazinamide were proven to be very effective in the treatme...
Main Authors: | Muhammad F. Wardhana, Tiana Milanda, Sri A. Sumiwi |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Padjadjaran
2018-04-01
|
Series: | Pharmacology and Clinical Pharmacy Research |
Online Access: | http://jurnal.unpad.ac.id/pcpr/article/view/16450 |
Similar Items
-
Modulation of Caspase-3 Expression by Arcangelisia flava Post Acetaminophen-Induced Hepatotoxicity in Rat’s Liver
by: Steffi Liem, et al.
Published: (2018-08-01) -
RISK ASSESSMENT AND MONITORING OF HEPATOTOXIC REACTIONS IN TUBERCULOSIS PATIENTS
by: D. A. IVАNOVА, et al.
Published: (2017-10-01) -
Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment
by: Williams Ngouleun, et al.
Published: (2016-01-01) -
Hepatotoxicity Effects of Alcohol Consumption during Paracetamol Therapy of Malaria Patients
by: Funny Dinge, et al.
Published: (2017-08-01) -
Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
by: Molla Y, et al.
Published: (2021-01-01)